Ssimusango: Multi-level intervention for intersectional stigma reduction to improve HIV outcomes for transgender women
西穆桑戈:多层次干预减少交叉耻辱,以改善跨性别女性的艾滋病毒结果
基本信息
- 批准号:10755926
- 负责人:
- 金额:$ 18.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-15 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAddressAdherenceAdoptionAdultAfrica South of the SaharaAfricanCaringCatchment AreaClinicClinicalClinical TrialsCommunitiesConsolidated Framework for Implementation ResearchConsultationsDataDisclosureDiscriminationEducationEffectivenessEmpathyEnrollmentEquityEvaluationFaceFeedbackFocus GroupsFrightGender IdentityGeneral PopulationHIVHIV InfectionsHealth PersonnelHealth PolicyHealth ServicesHealth StatusHealth care facilityHealthcareHigh Risk WomanHuman immunodeficiency virus testHybridsIncidenceIndividualInstitutionInterventionInterviewManualsMeasuresModelingOutcomePopulationPrevalencePreventionQualitative MethodsRNARandomizedResearchRiskSamplingServicesSex OrientationStigmatizationSurveysTenofovirTestingTrainingUgandaUrineViralWaiting ListsWell in selfWomanWorkacceptability and feasibilityagedantiretroviral therapyeffectiveness evaluationeffectiveness/implementation trialempowermentevidence baseexperiencegender minorityhealth assessmenthealth care settingshealth trainingimplementation evaluationimplementation interventionimplementation outcomesimprovedinformantinternalized stigmaintersectionalityintervention deliverymarginalized populationmenmen who have sex with menmultidisciplinarypeerperceived discriminationpilot testpost interventionpre-exposure prophylaxisprevention serviceprimary outcomeprogramsresidenceresponsescale upsecondary outcomesexsocial stigmastandard of caresynergismtherapy adherencetherapy designtransgendertransgender womentreatment servicesuptake
项目摘要
PROJECT SUMMARY/ABSTRACT
Transgender women (TGW) are at high risk for HIV infection, and are an important, under-researched key
population in sub-Saharan Africa. Globally, HIV acquisition risk among TGW is 14 times higher than other adults
aged 15-49 years. Intersectional stigma and discrimination (ISD) experienced by TGW at the intersections of
HIV, sexual orientation, gender minority identity and sex work results in poor engagement in care and suboptimal
adherence to HIV pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART). Much work remains in
addressing HIV-related ISD and scaling up treatment and prevention coverage for TGW. Two evidence-based
ISD-reduction interventions are available -- (1) Health Policy Plus (HP+) Total Facility Approach (TFA) to Stigma
Reduction (a clinic-level intervention) and (2) HIV Education, Empathy and Empowerment (HIVE3) (an individual-
level intervention) -- but these have not been adapted and implemented for TGW in sub-Saharan Africa. HP+
and HIVE3 are complementary interventions that could be combined to reduce health facility- and individual-level
stigma. However, research is needed to show if the adapted multi-level HP+/HIVE3 intervention, Ssimusango
(means “no self-blame or blaming others” in Luganda), decreases HIV-related stigma and improves HIV
outcomes for TGW. To address these questions, we will conduct a randomized wait-list controlled trial to test the
preliminary effectiveness of Ssimusango on PrEP adherence and viral suppression, compared with standard of
care, using a status-neutral approach i.e., engagement in care regardless of HIV status. We will also use
qualitative methods to assess mechanisms and synergies of intervention delivery. Leveraging the multi-
disciplinary expertise of our multi-national research team, and working at four health facilities in Kampala ranked
lowest on the PEPFAR Uganda stigma scorecard, we propose the following specific aims: (1) adapt the HP+
and HIVE3 stigma-reduction interventions to address ISD for TGW in Uganda (intervention adaptation); (2)
conduct a hybrid type 1 effectiveness-implementation trial with 120 TGW to pilot test the preliminary
effectiveness of Ssimusango on (a) PrEP adherence and (b) viral suppression (intervention implementation);
and (3) evaluate Ssimusango using qualitative methods and the Intersectionality-Enhanced Consolidated
Framework for Implementation Research (intervention evaluation). Clinic-level implementation outcomes are
adoption, fidelity, and sustainability assessed using key informant interviews, training attendance sheets,
observation checklists, and rapid feedback surveys. Individual-level outcomes: (1) PrEP adherence at 3 and 6
months post-intervention, measured by urine tenofovir levels (primary outcome) and (2) viral suppression (HIV
RNA <50 copies/mL) and (3) ISD reduction 6 months post-intervention (secondary outcomes). This multi-level
approach to implementing ISD interventions will improve PrEP and ART adherence outcomes among TGW -
“the most vulnerable of the vulnerable” -, build stigma research capacity in Uganda, and generate actionable
data for scale-up and program implementation in Uganda and sub-Saharan Africa.
项目总结/摘要
跨性别妇女(TGW)是艾滋病毒感染的高风险,是一个重要的,研究不足的关键
撒哈拉以南非洲的人口。在全球范围内,TGW感染艾滋病毒的风险是其他成年人的14倍
年龄15-49岁。TGW在以下交叉点经历的交叉羞辱和歧视:
艾滋病毒、性取向、性别少数认同和性工作导致护理参与不足,
坚持艾滋病毒暴露前预防(PrEP)和抗逆转录病毒治疗(ART)。还有很多工作要做,
解决与艾滋病毒相关的ISD问题并扩大TGW的治疗和预防覆盖范围。两个基于证据的
(1)“卫生政策+”(HP+)消除成见的“全面设施办法”(TFA)
减少(诊所一级的干预)和(2)艾滋病毒教育、同情和赋权(艾滋病毒3)(个人-
在撒哈拉以南非洲,这些措施尚未得到调整和实施。HP+
和艾滋病毒3是互补的干预措施,可以结合起来,以减少卫生设施和个人层面的
耻辱然而,需要进行研究,以表明经调整的多层次HP+/HIV-3干预,Ssimusango,
(在卢甘达语中的意思是“不自责或责怪他人”),减少与艾滋病毒有关的耻辱感,
TGW的结果。为了解决这些问题,我们将进行一项随机等待名单对照试验,以测试
Ssimusango对PrEP依从性和病毒抑制的初步有效性,与
护理,使用地位中立的方法,即,无论艾滋病毒状况如何,都要参与护理。我们还将使用
采用定性方法评估干预措施交付的机制和协同作用。利用多-
我们的多国研究团队的学科专业知识,并在坎帕拉的四个卫生设施的工作排名
在PEPFAR乌干达耻辱记分卡上排名最低,我们提出以下具体目标:(1)调整HP+
和艾滋病毒3减少耻辱干预措施,以解决乌干达过渡期妇女的综合性服务障碍问题(干预措施适应);(2)
利用120个TGW进行混合1型有效性实施试验,对初步的
Ssimusango对(a)PrEP依从性和(B)病毒抑制(实施干预)的有效性;
和(3)评价Ssimusango使用定性方法和交叉增强综合
实施研究框架(干预评估)。临床层面的实施结果是
采用,忠诚度和可持续性评估使用关键线人访谈,培训出勤表,
观察清单和快速反馈调查。个体水平的结果:(1)3岁和6岁时的PrEP依从性
干预后3个月,通过尿液替诺福韦水平(主要结局)和(2)病毒抑制(HIV
RNA <50拷贝/mL)和(3)干预后6个月ISD减少(次要结局)。该多电平
实施ISD干预措施的方法将改善TGW中的PrEP和ART依从性结果-
“弱势群体中最弱势的群体”-在乌干达建立污名化研究能力,
在乌干达和撒哈拉以南非洲扩大规模和实施方案的数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Mujugira其他文献
Andrew Mujugira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Mujugira', 18)}}的其他基金
Choice-Based PrEP Delivery for Transgender People in Uganda
为乌干达跨性别者提供基于选择的 PrEP 服务
- 批准号:
10545791 - 财政年份:2022
- 资助金额:
$ 18.62万 - 项目类别:
Choice-Based PrEP Delivery for Transgender People in Uganda
为乌干达跨性别者提供基于选择的 PrEP 服务
- 批准号:
10677722 - 财政年份:2022
- 资助金额:
$ 18.62万 - 项目类别:
Peer-Delivered HIV Self-Testing, STI Self-Sampling and PrEP for Transgender Women in Uganda
乌干达变性女性同伴提供的艾滋病毒自我检测、性传播感染自我采样和暴露前预防
- 批准号:
10170433 - 财政年份:2019
- 资助金额:
$ 18.62万 - 项目类别:
Peer-Delivered HIV Self-Testing, STI Self-Sampling and PrEP for Transgender Women in Uganda
乌干达变性女性同伴提供的艾滋病毒自我检测、性传播感染自我采样和暴露前预防
- 批准号:
9981832 - 财政年份:2019
- 资助金额:
$ 18.62万 - 项目类别:
Transgender Men and HIV in Uganda: PrEP Uptake and Persistence
乌干达的跨性别男性与艾滋病毒:PrEP 的采用和坚持
- 批准号:
10092257 - 财政年份:2019
- 资助金额:
$ 18.62万 - 项目类别:
HIV Self Testing to Empower Prevention Choices in Sex Workers
艾滋病毒自我检测可增强性工作者的预防选择
- 批准号:
9919021 - 财政年份:2017
- 资助金额:
$ 18.62万 - 项目类别:
HIV Self Testing to Empower Prevention Choices in Sex Workers
艾滋病毒自我检测可增强性工作者的预防选择
- 批准号:
9399733 - 财政年份:2017
- 资助金额:
$ 18.62万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 18.62万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 18.62万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 18.62万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 18.62万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 18.62万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 18.62万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 18.62万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 18.62万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 18.62万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 18.62万 - 项目类别: